Company / EPS (Diluted)
Bio Essence Corp EPS (Diluted) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.03
FY2024
5-year range
-$0.03 / -$0.02
FY2021-FY2024
Trend
-50.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.02 to $-0.03 over the past 2 years.
Based on SEC 10-K filings.
-0.03 in FY2024.
Declined from $-0.02 to $-0.03 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, eps (diluted) decreased 50.0% year-over-year.
Company context
Key Data Points
- High Piotroski F-Score: 9/9 (strong financial health signals)
- Altman Z-Score -11.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$0.03 | -50.0% |
| FY2023 | -$0.02 | +0.0% |
| FY2022 | -$0.02 | +0.0% |
| FY2021 | -$0.02 | - |
As of FY2024 · SEC Form 10-K · Last checked Jun 29, 2026